Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/Rb2 (Q39653282)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 18, 2010

Language	Label	Description	Also known as
English	Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/Rb2	scientific article published on November 18, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/Rb2 (English)

1 reference

10.1002/IJC.25692

https://api.crossref.org/works/10.1002/IJC.25692

17 July 2024

1 reference

based on heuristic

inferred from title

author name string

Jing Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hassan Nakhla

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Eileen Friedman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

18 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.25692

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20857490

17 July 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.25692

1 reference

10.1002/IJC.25692

https://api.crossref.org/works/10.1002/IJC.25692

17 July 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.25692

1 reference

10.1002/IJC.25692

https://api.crossref.org/works/10.1002/IJC.25692

17 July 2024

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

307-318

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Control of the reversibility of cellular quiescence by the transcriptional repressor HES1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

The expression of the testis-specific Dyrk4 kinase is highly restricted to step 8 spermatids but is not required for male fertility in mice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

A new description of cellular quiescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Frequent loss of pRb2/p130 in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk regulates the exit of colon cancer cells from quiescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Amplification of 19q13.1–q13.2 sequences in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25692

21 January 2018

Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow

8

1 reference

10.1002/IJC.25692

https://api.crossref.org/works/10.1002/IJC.25692

17 July 2024

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

10

1 reference

10.1002/IJC.25692

https://api.crossref.org/works/10.1002/IJC.25692

17 July 2024

Identifiers

10.1002/IJC.25692

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39653282&oldid=2206459557"